FDA Poised to Ease Restrictions on Injectable Peptides Af BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification Is BPC 157 Banned? Oral vs. Injectable Forms Explained Are Peptides coming off of the FDA Category 2 list? A legal breakdown. FDA Peptide Update: Category 2 Removals Explained The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York